Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Nanexa AB (publ)
  6. News
  7. Summary
    NANEXA   SE0007074166

NANEXA AB (PUBL)

(NANEXA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Nanexa : EPO communicates intention to grant Nanexa's PharmaShell« patent in Europe

07/07/2021 | 10:36am EDT

Nanexa AB is pleased to announce that the European Patent Office (EPO) has today issued a communication advising that it intends to grant a European patent relating to Nanexa’s PharmaShell® technology.

Following completion of some internal checks and the necessary formal requirements, a patent will grant, all being well, within the next few months.
 

© Modular Finance, source Nordic Press Releases

All news about NANEXA AB (PUBL)
10/25NANEXA : initiates complementary preclinical studies
AQ
10/13NANEXA : signs additional evaluation agreement
AQ
10/05NANEXA : receives decision on sanction fee from Finansinspektionen regarding case from 201..
AQ
09/24NANEXA : pauses NEX-18 study
AQ
09/24Nanexa Announces Inclusion of Patients in its Phase I Study with NEX-18
CI
09/03NANEXA : receives orders for coating of sensors
AQ
09/03Nanexa Receives Orders for Coating of Sensors
CI
08/20NANEXA : publishes interim report for January – June 2021
AQ
08/20Nanexa AB Announces Earnings Results for the Second Quarter and Six Months Ended June 3..
CI
07/07NANEXA : EPO communicates intention to grant Nanexa's PharmaShell« patent in Europe
AQ
More news
Financials
Sales 2021 23,0 M 2,67 M 2,67 M
Net income 2021 -29,0 M -3,37 M -3,37 M
Net cash 2021 112 M 13,0 M 13,0 M
P/E ratio 2021 -6,74x
Yield 2021 -
Capitalization 195 M 22,6 M 22,6 M
EV / Sales 2021 3,59x
EV / Sales 2022 4,75x
Nbr of Employees 13
Free-Float 81,8%
Chart NANEXA AB (PUBL)
Duration : Period :
Nanexa AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 3,84 SEK
Average target price 7,00 SEK
Spread / Average Target 82,3%
EPS Revisions
Managers and Directors
David Westberg Chief Executive Officer
Bj÷rn Wilhelm Svanstr÷m Chief Financial Officer
G÷ran Albert Torstensson Ando Chairman
Magnus Westgren Independent Director
Bengt Arne Gustavsson Independent Director
Sector and Competitors
1st jan.Capi. (M$)
NANEXA AB (PUBL)-65.19%23
ABBOTT LABORATORIES15.61%224 403
MEDTRONIC PLC5.48%166 288
STRYKER CORPORATION11.43%102 966
BECTON, DICKINSON AND COMPANY-1.52%70 767
HOYA CORPORATION20.25%55 682